This report explores how real-world data (RWD) transforms medicine and pharma by accelerating drug discovery, clinical trials, and regulatory approvals. It highlights use cases in the U.S., China, and Europe, from FDA guidance on RWD integration to China’s pilot zones for faster drug approval and Europe’s GDPR-driven frameworks. Case studies include Flatiron Health and ConcertAI’s oncology RWD initiatives, which enabled faster approvals and improved outcomes. NTT DATA emphasizes building interoperable infrastructure, legal frameworks, and partnerships to leverage RWD fully. The goal is patient-centric, data-driven healthcare that improves quality, speed, and efficiency.

Join for free to read